Patents by Inventor Guanpingsheng Luo

Guanpingsheng Luo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HYR1-derived compositions and methods of treatment using same
    Patent number: 10160790
    Abstract: The disclosure features isolated polypeptides of Hyr1. The disclosure further features vaccines and antibodies useful in treating or preventing candidiasis or Acinetobacter infections or both. Further disclosed are isolated polypeptides consisting of between 14 and 20 amino acids for vaccine preparation. The specific amino acid sequences of isolated polypeptides of Hyr1 are also disclosed.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: December 25, 2018
    Assignee: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
    Inventors: Ashraf S. Ibrahim, Michael R. Yeaman, John E. Edwards, Jr., Guanpingsheng Luo, Yue Fu
  • HYR1-DERIVED COMPOSITIONS AND METHODS OF TREATMENT USING SAME
    Publication number: 20150191514
    Abstract: The disclosure features isolated polypeptides of Hyr1. The disclosure further features vaccines and antibodies useful in treating or preventing candidiasis or Acinetobacter infections or both. Further disclosed are isolated polypeptides consisting of between 14 and 20 amino acids for vaccine preparation. The specific amino acid sequences of isolated polypeptides of Hyr1 are also disclosed.
    Type: Application
    Filed: September 14, 2012
    Publication date: July 9, 2015
    Applicant: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
    Inventors: Ashraf S. Ibrahim, Michael R. Yeaman, John E. Edwards, JR., Guanpingsheng Luo, Yue Fu
  • COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST DRUG RESISTANT ACINETOBACTER BAUMANNII
    Publication number: 20140335092
    Abstract: The present invention provides vaccine compositions comprising OmpA, or antigenic fragments thereof, and related methods of active immunization against A. baumannii infection. The invention also provides antibodies and antigen-binding parts thereof that specifically bind to OmpA, and related methods of passive immunization against A. baumannii infection. The compositions and methods of the invention are useful for preventing or treating A. baumannii infections, including those caused by strains resistant to carbapenems and all other antibiotics except colistin or tigecycline, also referred to as extreme drug resistant (XDR) A. baumannii infections, and those resistant to every FDA approved antibiotic, also referred to as pan-drug resistant (PDR) A. baumannii infections.
    Type: Application
    Filed: May 15, 2014
    Publication date: November 13, 2014
    Applicant: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
    Inventors: Brad J. SPELLBERG, Lin LIN, Ashraf IBRAHIM, Guanpingsheng LUO
  • HYR1 AS A TARGET FOR ACTIVE AND PASSIVE IMMUNIZATION AGAINST CANDIDA
    Publication number: 20140335114
    Abstract: The invention features HYR1 as a vaccine target and as a prophylactic strategy for combating disseminated candidiasis.
    Type: Application
    Filed: April 17, 2014
    Publication date: November 13, 2014
    Applicant: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
    Inventors: Yue FU, Guanpingsheng Luo, Ashraf S. Ibrahim, Brad Spellberg, John E. Edwards, JR.
  • Compositions and methods for immunization against drug resistant
    Patent number: 8747846
    Abstract: The present invention provides vaccine compositions comprising OmpA, or antigenic fragments thereof, and related methods of active immunization against A. baumannii infection. The invention also provides antibodies and antigen-binding parts thereof that specifically bind to OmpA, and related methods of passive immunization against A. baumannii infection. The compositions and methods of the invention are useful for preventing or treating A. baumannii infections, including those caused by strains resistant to carbapenems and all other antibiotics except colistin or tigecycline, also referred to as extreme drug resistant (XDR) A. baumannii infections, and those resistant to every FDA approved antibiotic, also referred to as pan-drug resistant (PDR) A. baumannii infections.
    Type: Grant
    Filed: May 11, 2012
    Date of Patent: June 10, 2014
    Assignee: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
    Inventors: Brad J. Spellberg, Lin Lin, Ashraf Ibrahim, Guanpingsheng Luo
  • HYR1 as a target for active and passive immunization against
    Patent number: 8709446
    Abstract: The invention features HYR1 as a vaccine target and as a prophylactic strategy for combating disseminated candidiasis.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: April 29, 2014
    Assignee: Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center
    Inventors: Yue Fu, Guanpingsheng Luo, Ashraf Ibrahim, Brad Spellberg, John Edwards, Jr.
  • COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST DRUG RESISTANT ACINETOBACTER BAUMANNII
    Publication number: 20120301474
    Abstract: The present invention provides vaccine compositions comprising OmpA, or antigenic fragments thereof, and related methods of active immunization against A. baumannii infection. The invention also provides antibodies and antigen-binding parts thereof that specifically bind to OmpA, and related methods of passive immunization against A. baumannii infection. The compositions and methods of the invention are useful for preventing or treating A. baumannii infections, including those caused by strains resistant to carbapenems and all other antibiotics except colistin or tigecycline, also referred to as extreme drug resistant (XDR) A. baumannii infections, and those resistant to every FDA approved antibiotic, also referred to as pan-drug resistant (PDR) A. baumannii infections.
    Type: Application
    Filed: May 11, 2012
    Publication date: November 29, 2012
    Applicant: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
    Inventors: Brad J. Spellberg, Lin Lin, Ashraf Ibrahim, Guanpingsheng Luo
  • HYR1 AS A TARGET FOR ACTIVE AND PASSIVE IMMUNIZATION AGAINST CANDIDA
    Publication number: 20120237534
    Abstract: The invention features HYR1 as a vaccine target and as a prophylactic strategy for combating disseminated candidiasis.
    Type: Application
    Filed: July 2, 2010
    Publication date: September 20, 2012
    Applicant: LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER
    Inventors: Yue Fu, Guanpingsheng Luo, Ashraf Ibrahim, Brad Spellberg, John Edwards, JR.